(PharmaNewsWire.Com, December 26, 2017 ) The North America Flow Cytometry market has been estimated at USD 1155 Million in 2016 and is projected to reach USD 1868 Million by 2021, at a CAGR of 10.1% during the forecast period from 2016 to 2021.
Flow cytometry is a laser or impedance-based technology used in cell sorting, cell counting, biomarker detection, and protein engineering. It allows for in-depth analysis of cell structures using the software. Flow cytometry is being used extensively in pharmacodynamic studies for some specific areas such as oncology and immunology.
The market for Flow Cytometry is mainly driven due to technological advancements and high adoption in various research and diagnostic applications. Also, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. But, the market growth is restrained due to high maintenance and operational cost associated with instruments and reagents.
North America market for Flow Cytometry is segmented based on Technology, Product, Application, and End-users. By Technology, the market is further sub-segmented into Cell-based and Bead-based. By Product, the market is further sub-segmented into Reagents & Consumables, Flow Cytometry Instruments (Cell Analyzers, Cell Sorters). By Application, the market is further sub-segmented into Research, Clinical, and Industrial. By End-users, the market is further sub-segmented into Commercial Organizations, Research Institutes, Clinical Testing Labs, Hospitals and Academic Institutions & Medical Schools. The cell-based flow cytometry technology accounts for the largest share, by technology. Research applications segment accounts for the largest share, by the application. The commercial organizations end-user segment accounts for the largest share, by the end user.
Geographically, North America market for Flow Cytometry is segmented into U.S. and Canada. North America is the biggest market in terms of market share across the globe, followed by Europe. The market in North America is highly driven due to factors like increasing application of flow cytometry techniques in cancer research, increasing adoption of low cost and compact flow cytometers in clinical diagnostics and research laboratories, and increasing quality of infrastructure for laboratory and clinical research.
Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Thermo Fischer Scientific, Agilent Technologies, Inc. and Affymetix Inc., are the major players of North America Flow Cytometry market.
The scope of the report: • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
